Search Results - "Monster, Taco B M"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    The impact of antihypertensive drug groups on urinary albumin excretion in a non‐diabetic population by Monster, Taco B. M., Janssen, Wilbert M. T., De Jong, Paul E., De Jong‐van den Berg, Lolkje T. W.

    Published in British journal of clinical pharmacology (01-01-2002)
    “…Aims  Microalbuminuria (30–300 mg 24 h−1) is recognized to be independently associated with renal and cardiovascular risk. Antihypertensives may lower…”
    Get full text
    Journal Article
  2. 2

    Factors Influencing Preferences and Responses Towards Drug Safety Communications: A Conjoint Experiment Among Hospital-Based Healthcare Professionals in the Netherlands by de Vries, Esther, Bakker, Elisabeth, Monster, Taco B. M., Denig, Petra, Mol, Peter G. M.

    Published in Drug safety (01-11-2022)
    “…Introduction Healthcare professionals (HCPs) are informed about new drug safety issues through Direct Healthcare Professional Communications (DHPCs). The…”
    Get full text
    Journal Article
  3. 3

    Pharmacy data in epidemiological studies: an easy to obtain and reliable tool by Monster, Taco B. M., Janssen, Wilbert M. T., de Jong, Paul E., de Jong-van den Berg, Lolkje T. W.

    Published in Pharmacoepidemiology and drug safety (01-07-2002)
    “…Purpose The agreement between drug use measured in computerized pharmacy records and patient interviews or questionnaires is generally good. However, most…”
    Get full text
    Journal Article
  4. 4

    Drug Safety Issues Covered by Lay Media: A Cohort Study of Direct Healthcare Provider Communications Sent between 2001 and 2015 in The Netherlands by de Vries, Esther, Denig, Petra, de Vries, Sieta T., Monster, Taco B. M., Hugtenburg, Jacqueline G., Mol, Peter G. M.

    Published in Drug safety (01-07-2020)
    “…Background Some drug safety issues communicated through direct healthcare professional communications (DHPCs) receive substantial media coverage, while others…”
    Get full text
    Journal Article
  5. 5

    The effect of hypertension and hypercholesterolemia screening with subsequent intervention letter on the use of blood pressure and lipid lowering drugs by Atthobari, Jarir, Monster, Taco BM, De Jong, Paul E, De Jong‐van den Berg, Lolkje TW

    Published in British journal of clinical pharmacology (01-03-2004)
    “…Aim  To evaluate the effect of a letter intervention that was send to both the participants of a population screening and their general practitioners. We also…”
    Get full text
    Journal Article
  6. 6

    Antidepressants and risk of first-time hospitalization for myocardial infarction: a population-based case-control study by Monster, Taco B M, Johnsen, Søren P, Olsen, Mette L, McLaughlin, Joseph K, Sørensen, Henrik T

    Published in The American journal of medicine (15-11-2004)
    “…Several studies have found an increased risk of myocardial infarction among depressed patients. Selective serotonin reuptake inhibitors (SSRIs) appear to lack…”
    Get more information
    Journal Article
  7. 7

    Oral contraceptive use and hormone replacement therapy are associated with microalbuminuria by Monster, T B, Janssen, W M, de Jong, P E, de Jong-van den Berg, L T

    Published in Archives of internal medicine (1960) (10-09-2001)
    “…Controversy exists regarding the adverse and beneficial effects of oral contraceptive use and hormone replacement therapy. Microalbuminuria is associated with…”
    Get more information
    Journal Article
  8. 8
  9. 9

    How to estimate the population that is covered by community pharmacies? An evaluation of two methods using drug utilisation information by Schirm, Eric, Monster, Taco B. M., de Vries, Robin, van den Berg, Paul B., de Jong-van den Berg, Lolkje T. W., Tobi, Hilde

    Published in Pharmacoepidemiology and drug safety (01-03-2004)
    “…Purpose Pharmacy‐dispensing data are valuable sources of drug information, but the population that is covered by the pharmacies is often difficult to…”
    Get full text
    Journal Article
  10. 10

    Drug-induced renal function impairment: a population-based survey by Monster, Taco B. M., de Jong, Paul E., de Jong-van den Berg, Lolkje T. W.

    Published in Pharmacoepidemiology and drug safety (01-03-2003)
    “…Purpose The knowledge that drugs can affect renal function is mainly based on experimental studies or case reports. Thus, it has only been investigated in…”
    Get full text
    Journal Article
  11. 11

    Chlorpromazine equivalents versus defined daily doses: how to compare antipsychotic drug doses? by Rijcken, Claudia A W, Monster, Taco B M, Brouwers, Jacobus R B J, de Jong-van den Berg, Lolkje T W

    Published in Journal of clinical psychopharmacology (01-12-2003)
    “…Classic chlorpromazine (CPZ) equivalents can be used to chart relative antipsychotic potencies of antipsychotic drugs. Values of CPZ equivalents per drug are…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Antibiotics and risk of first-time hospitalization for myocardial infarction: a population-based case-control study by Monster, Taco B M, Johnsen, Søren P, Olsen, Mette L, Ostergaard, Lars, Friis, Søren, McLaughlin, Joseph K, Sørensen, Henrik T

    Published in American journal of therapeutics (01-05-2005)
    “…There is increasing evidence that inflammation plays an important role in atherosclerosis. Such inflammation is likely related to the presence of infectious…”
    Get full text
    Journal Article
  14. 14

    Corticosteroid use and its association with microalbuminuria in the adult population by Monster, Taco B.M., Janssen, Wilbert M.T., de Jong, Paul E., de Jong-van de Berg, Lolkje T.W.

    Published in Pulmonary pharmacology & therapeutics (01-01-2003)
    “…Background. Corticosteroids exhibit a wide range of adverse effects, among which are a number of cardiovascular effects. Microalbuminuria shows a strong…”
    Get full text
    Journal Article